Vitrolife AB (publ) (VITR.ST)
SEK 214.4
(1.13%)
SEK 214.4
(1.13%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.08 Billion SEK | -6.11% |
| 2022 | 2.22 Billion SEK | -10.37% |
| 2021 | 2.48 Billion SEK | 3878.16% |
| 2020 | 62.4 Million SEK | -17.72% |
| 2019 | 75.84 Million SEK | 0.0% |
| 2018 | - SEK | -100.0% |
| 2017 | 480 Thousand SEK | -98.73% |
| 2016 | 37.85 Million SEK | -20.31% |
| 2015 | 47.5 Million SEK | -44.63% |
| 2014 | 85.79 Million SEK | 121.97% |
| 2013 | 38.65 Million SEK | -48.5% |
| 2012 | 75.05 Million SEK | 12.07% |
| 2011 | 66.96 Million SEK | 28.35% |
| 2010 | 52.17 Million SEK | 412.85% |
| 2009 | 10.17 Million SEK | 55.61% |
| 2008 | 6.53 Million SEK | 0.0% |
| 2007 | - SEK | 0.0% |
| 2006 | - SEK | 0.0% |
| 2005 | - SEK | 0.0% |
| 2004 | - SEK | 0.0% |
| 2003 | - SEK | 0.0% |
| 2002 | - SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.07 Billion SEK | -0.91% |
| 2024 Q3 | 1.92 Billion SEK | -2.15% |
| 2024 Q2 | 2.09 Billion SEK | 1.21% |
| 2023 FY | 2.08 Billion SEK | -6.11% |
| 2023 Q4 | 2.08 Billion SEK | -3.11% |
| 2023 Q3 | 2.15 Billion SEK | -5.19% |
| 2023 Q2 | 2.27 Billion SEK | 5.52% |
| 2023 Q1 | 2.15 Billion SEK | -3.15% |
| 2022 Q1 | 2.45 Billion SEK | -1.03% |
| 2022 Q4 | 2.22 Billion SEK | 0.77% |
| 2022 FY | 2.22 Billion SEK | -10.37% |
| 2022 Q3 | 2.2 Billion SEK | -5.76% |
| 2022 Q2 | 2.34 Billion SEK | -4.64% |
| 2021 Q2 | 71.82 Million SEK | 19.62% |
| 2021 FY | 2.48 Billion SEK | 3878.16% |
| 2021 Q1 | 60.04 Million SEK | -3.78% |
| 2021 Q4 | 2.48 Billion SEK | 3535.54% |
| 2021 Q3 | 68.28 Million SEK | -4.93% |
| 2020 Q1 | 74.69 Million SEK | -1.51% |
| 2020 Q4 | 62.4 Million SEK | -6.33% |
| 2020 FY | 62.4 Million SEK | -17.72% |
| 2020 Q2 | 71.03 Million SEK | -4.9% |
| 2020 Q3 | 66.62 Million SEK | -6.22% |
| 2019 Q2 | 79.31 Million SEK | 3.17% |
| 2019 Q1 | 76.87 Million SEK | 0.0% |
| 2019 FY | 75.84 Million SEK | 0.0% |
| 2019 Q4 | 75.84 Million SEK | -3.4% |
| 2019 Q3 | 78.51 Million SEK | -1.01% |
| 2018 Q1 | 481 Thousand SEK | 0.21% |
| 2018 Q2 | - SEK | -100.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q4 | - SEK | 0.0% |
| 2018 FY | - SEK | -100.0% |
| 2017 FY | 480 Thousand SEK | -98.73% |
| 2017 Q4 | 480 Thousand SEK | -1.23% |
| 2017 Q3 | 486 Thousand SEK | -98.48% |
| 2017 Q2 | 31.95 Million SEK | -7.8% |
| 2017 Q1 | 34.65 Million SEK | -8.46% |
| 2016 Q1 | 45 Million SEK | -5.25% |
| 2016 Q4 | 37.85 Million SEK | -8.26% |
| 2016 Q3 | 41.26 Million SEK | -4.97% |
| 2016 Q2 | 43.42 Million SEK | -3.53% |
| 2016 FY | 37.85 Million SEK | -20.31% |
| 2015 Q1 | 73.69 Million SEK | -14.1% |
| 2015 Q4 | 47.5 Million SEK | -8.65% |
| 2015 Q3 | 52 Million SEK | -23.64% |
| 2015 Q2 | 68.09 Million SEK | -7.6% |
| 2015 FY | 47.5 Million SEK | -44.63% |
| 2014 Q3 | 27.4 Million SEK | -11.88% |
| 2014 Q4 | 85.79 Million SEK | 213.08% |
| 2014 Q2 | 31.09 Million SEK | -9.62% |
| 2014 Q1 | 34.4 Million SEK | -10.98% |
| 2014 FY | 85.79 Million SEK | 121.97% |
| 2013 Q4 | 38.65 Million SEK | -16.2% |
| 2013 Q2 | 65.07 Million SEK | -1.85% |
| 2013 Q1 | 66.3 Million SEK | -11.66% |
| 2013 Q3 | 46.12 Million SEK | -29.13% |
| 2013 FY | 38.65 Million SEK | -48.5% |
| 2012 Q1 | 63.41 Million SEK | -5.31% |
| 2012 Q4 | 75.05 Million SEK | -83.26% |
| 2012 FY | 75.05 Million SEK | 12.07% |
| 2012 Q2 | 66.36 Million SEK | 4.65% |
| 2012 Q3 | 448.26 Million SEK | 575.44% |
| 2011 Q3 | 69.85 Million SEK | 4.38% |
| 2011 Q1 | 61.88 Million SEK | 18.61% |
| 2011 Q2 | 66.92 Million SEK | 8.14% |
| 2011 FY | 66.96 Million SEK | 28.35% |
| 2011 Q4 | 66.96 Million SEK | -4.13% |
| 2010 FY | 52.17 Million SEK | 412.85% |
| 2010 Q4 | 52.17 Million SEK | 231.85% |
| 2010 Q3 | 15.72 Million SEK | 14.93% |
| 2010 Q2 | 13.68 Million SEK | 0.0% |
| 2009 Q4 | 10.17 Million SEK | 0.0% |
| 2009 FY | 10.17 Million SEK | 55.61% |
| 2008 FY | 6.53 Million SEK | 0.0% |
| 2007 FY | - SEK | 0.0% |
| 2006 FY | - SEK | 0.0% |
| 2005 FY | - SEK | 0.0% |
| 2004 FY | - SEK | 0.0% |
| 2003 FY | - SEK | 0.0% |
| 2002 FY | - SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | -29.478% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | -29.478% |
| Arcoma AB | 3.87 Million SEK | -53837.516% |
| Bactiguard Holding AB (publ) | 233.09 Million SEK | -796.186% |
| BICO Group AB (publ) | 1.85 Billion SEK | -12.73% |
| Boule Diagnostics AB (publ) | 166.1 Million SEK | -1157.676% |
| CellaVision AB (publ) | 64.7 Million SEK | -3128.598% |
| Clinical Laserthermia Systems AB (publ) | 454 Thousand SEK | -460032.159% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.8 Million SEK | -115955.556% |
| Duearity AB (publ) | 10.58 Million SEK | -19641.07% |
| Dignitana AB (publ) | 19.1 Million SEK | -10834.883% |
| Episurf Medical AB (publ) | 5.2 Million SEK | -40073.077% |
| Getinge AB (publ) | 8.07 Billion SEK | 74.133% |
| Scandinavian Real Heart AB (Publ) | 8.24 Million SEK | -25222.363% |
| Iconovo AB (publ) | 7.72 Million SEK | -26942.386% |
| Integrum AB (publ) | 6.42 Million SEK | -32417.764% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -1013859.539% |
| Mentice AB (publ) | 9.55 Million SEK | -21758.324% |
| OssDsign AB (publ) | 3.15 Million SEK | -66217.46% |
| Paxman AB (publ) | 13.57 Million SEK | -15294.252% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 20.73 Million SEK | -9976.697% |
| SciBase Holding AB (publ) | 6.79 Million SEK | -30634.147% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 31.78 Million SEK | -6471.662% |
| Sedana Medical AB (publ) | 4.3 Million SEK | -48413.702% |
| Senzime AB (publ) | 11.46 Million SEK | -18115.905% |
| SpectraCure AB (publ) | 6.71 Million SEK | -31000.194% |
| Stille AB | 62.94 Million SEK | -3218.929% |
| Xvivo Perfusion AB (publ) | 31.43 Million SEK | -6545.036% |